Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.
about
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesAllogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.Dynamics of Epstein-Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy.Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation.
P2860
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Impact of Epstein Barr virus-r ...... era of pre-emptive rituximab.
@en
type
label
Impact of Epstein Barr virus-r ...... era of pre-emptive rituximab.
@en
prefLabel
Impact of Epstein Barr virus-r ...... era of pre-emptive rituximab.
@en
P2093
P2860
P50
P356
P1476
Impact of Epstein Barr virus-r ...... e era of pre-emptive rituximab
@en
P2093
A Esquirol
I García-Cadenas
N Castillo
P2860
P2888
P304
P356
10.1038/BMT.2014.298
P407
P577
2015-01-12T00:00:00Z
P6179
1012623266